Fast Break: Personalized Medicine and Clinical Trials in 2023

Join us for our next edition of Fast Break, where we discuss clinical trial and personalized medicine developments for 2023 and the US Food and Drug Administration’s response to these matters.

As medical technologies have evolved, new opportunities have developed for healthcare entities to become further involved in product development and production. However, with new opportunities comes new regulatory considerations and risks.

Partner Jacqueline R. Berman and associate Alexandre Gapihan will take a look at some of the innovative ways companies are conducting clinical trials and making advances in medicine.

TOPICS WILL INCLUDE:

• Decentralized clinical research trials
• Personalized medicine development and manufacturing
• Legal requirements and considerations for entry into new regulatory areas

Don't forget you can view any of our previous webinars on our Fast Break series page >>